Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself

Qiankun Yang, Tong Chen, Shiqi Wang, Xiaojing Zhang, Zhongxiang Yao